Table 1.
Summary of bacterial strains sensitivity to APS agents plotted in Figure 5.
| Strain Name | Genotype | Pathway Deficiency | Percent Viability to 0.5 mM CTP-Cl | Percent Viability to 2.5 mM TPP-Br |
|---|---|---|---|---|
| AB1157 | WT | 33.4 | 18.2 | |
| GM5560 | recA- | HRR | 71.0 | 30.4 |
| AB2500 | uvrA-/thyA-/deoB- | NER | 26.8 | 30.5 |
| BW528 | xth-/nfo- | BER | 45.3 | 36.8 |
| W3110 | WT | 55.0 | 32.7 | |
| HL951 | recQ- | HRR/DNA Stability | 55.6 | 57.0 |
| BW25113 | WT | 36.5 | 9.5 | |
| JW4128 | mutL- | MMR | 27.4 | 10.0 |
| BW25113 | WT | 53.4 | 9.6 | |
| JW0221 | dinB- | Bypass | 54.3 | 9.5 |
| JW1172 | umuC- | Bypass | 57.3 | 8.9 |
| JW1173 | umuD- | Bypass | 51.8 | 6.0 |
| JW3835 | polA- | Exonuclease involved in Bypass | 49.1 | 8.4 |